CEL-SCI Corporation (CVM)
USD 0.62
(-18.09%)
USD 0.62
(-18.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -27.56 Million USD | 14.3% |
| 2022 | -31.73 Million USD | 0.4% |
| 2021 | -33.96 Million USD | -24.66% |
| 2020 | -26.82 Million USD | -37.75% |
| 2019 | -19.56 Million USD | -151.4% |
| 2018 | -16.12 Million USD | 76.42% |
| 2017 | -9.69 Million USD | 19.55% |
| 2016 | -9.08 Million USD | -16.0% |
| 2015 | -32.72 Million USD | -24.83% |
| 2014 | -26.97 Million USD | -40.4% |
| 2013 | -17.38 Million USD | -16.84% |
| 2012 | -14.68 Million USD | -67.84% |
| 2011 | -24.85 Million USD | 78.91% |
| 2010 | 9.62 Million USD | -377.63% |
| 2009 | -40.09 Million USD | 255.69% |
| 2008 | -9.04 Million USD | -22.38% |
| 2007 | -7.99 Million USD | -239.85% |
| 2006 | -5.07 Million USD | 46.54% |
| 2005 | -3.89 Million USD | -27.98% |
| 2004 | -3.88 Million USD | -131.39% |
| 2003 | -1.64 Million USD | 58.71% |
| 2002 | -3.99 Million USD | 64.09% |
| 2001 | -10.81 Million USD | -33.27% |
| 2000 | -8.29 Million USD | -12.68% |
| 1999 | -7.3 Million USD | 2.63% |
| 1998 | -6.2 Million USD | 5.0% |
| 1997 | -7.9 Million USD | -29.03% |
| 1996 | -6.3 Million USD | -87.88% |
| 1995 | -3.4 Million USD | 31.25% |
| 1994 | -4.4 Million USD | -182.35% |
| 1993 | -2 Million USD | -54.55% |
| 1992 | -1.1 Million USD | -120.0% |
| 1991 | -500 Thousand USD | -25.0% |
| 1990 | -400 Thousand USD | 50.0% |
| 1989 | -800 Thousand USD | 38.46% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -6.08 Million USD | -10.28% |
| 2024 Q3 | -5.68 Million USD | 6.43% |
| 2024 Q1 | -5.5 Million USD | 14.62% |
| 2023 Q2 | -7.19 Million USD | -7.24% |
| 2023 Q4 | -6.45 Million USD | 10.41% |
| 2023 Q3 | -7.19 Million USD | -0.02% |
| 2023 FY | - USD | 14.3% |
| 2023 Q1 | -6.71 Million USD | 14.58% |
| 2022 Q3 | -7.74 Million USD | 9.71% |
| 2022 Q1 | -7.98 Million USD | -4.49% |
| 2022 Q2 | -8.57 Million USD | -7.34% |
| 2022 FY | - USD | 0.4% |
| 2022 Q4 | -7.85 Million USD | -1.52% |
| 2021 Q1 | -8.05 Million USD | -3.61% |
| 2021 Q2 | -7.42 Million USD | 7.82% |
| 2021 Q3 | -9.15 Million USD | -23.24% |
| 2021 FY | - USD | -24.66% |
| 2021 Q4 | -7.64 Million USD | 16.52% |
| 2020 Q4 | -7.77 Million USD | -5.57% |
| 2020 FY | - USD | -37.75% |
| 2020 Q3 | -7.36 Million USD | -41.59% |
| 2020 Q2 | -5.2 Million USD | 26.92% |
| 2020 Q1 | -7.12 Million USD | 11.87% |
| 2019 FY | - USD | -151.4% |
| 2019 Q1 | -10.43 Million USD | -292.86% |
| 2019 Q2 | -3.17 Million USD | 69.55% |
| 2019 Q3 | 2.89 Million USD | 191.01% |
| 2019 Q4 | -8.07 Million USD | -379.33% |
| 2018 Q2 | -5.2 Million USD | -37.13% |
| 2018 Q1 | -3.79 Million USD | -22.5% |
| 2018 Q3 | -3.88 Million USD | 25.41% |
| 2018 FY | - USD | 76.42% |
| 2018 Q4 | 5.41 Million USD | 239.31% |
| 2017 Q2 | -8.3 Million USD | 41.98% |
| 2017 FY | - USD | 19.55% |
| 2017 Q4 | -3.1 Million USD | 48.3% |
| 2017 Q1 | -14.31 Million USD | -9.61% |
| 2017 Q3 | -5.99 Million USD | 27.79% |
| 2016 FY | - USD | -16.0% |
| 2016 Q1 | -13.86 Million USD | -67.66% |
| 2016 Q4 | -13.05 Million USD | -47.48% |
| 2016 Q3 | -8.85 Million USD | -143.19% |
| 2016 Q2 | -3.64 Million USD | 73.74% |
| 2015 Q4 | -8.26 Million USD | -1.79% |
| 2015 FY | - USD | -24.83% |
| 2015 Q1 | -9.91 Million USD | -17.64% |
| 2015 Q3 | -8.12 Million USD | -5.84% |
| 2015 Q2 | -7.67 Million USD | 22.54% |
| 2014 FY | - USD | -40.4% |
| 2014 Q2 | -6.14 Million USD | -5.1% |
| 2014 Q3 | -6.8 Million USD | -10.76% |
| 2014 Q4 | -8.42 Million USD | -23.78% |
| 2014 Q1 | -5.84 Million USD | -17.32% |
| 2013 Q2 | -4.11 Million USD | 15.63% |
| 2013 FY | - USD | -16.84% |
| 2013 Q4 | -4.98 Million USD | 7.81% |
| 2013 Q3 | -5.4 Million USD | -31.24% |
| 2013 Q1 | -4.88 Million USD | -24.42% |
| 2012 Q1 | -5.26 Million USD | -237.21% |
| 2012 Q4 | -3.92 Million USD | 47.64% |
| 2012 Q3 | -7.49 Million USD | -8875.11% |
| 2012 Q2 | 85.39 Thousand USD | 101.62% |
| 2012 FY | - USD | -67.84% |
| 2011 Q1 | -4.12 Million USD | 88.08% |
| 2011 Q4 | 3.83 Million USD | 182.02% |
| 2011 Q2 | 3.98 Million USD | 196.7% |
| 2011 FY | - USD | 78.91% |
| 2011 Q3 | -4.67 Million USD | -217.29% |
| 2010 Q2 | -5.09 Million USD | -33.49% |
| 2010 Q1 | -3.82 Million USD | -115.61% |
| 2010 Q3 | -3.17 Million USD | 37.65% |
| 2010 Q4 | -34.58 Million USD | -987.72% |
| 2010 FY | - USD | -377.63% |
| 2009 Q4 | 24.47 Million USD | 952.81% |
| 2009 Q3 | -2.87 Million USD | -70.12% |
| 2009 Q2 | -1.68 Million USD | 5.23% |
| 2009 FY | - USD | 255.69% |
| 2009 Q1 | -1.78 Million USD | 55.97% |
| 2008 FY | - USD | -22.38% |
| 2008 Q4 | -4.04 Million USD | -75.81% |
| 2008 Q1 | -3.72 Million USD | -4.86% |
| 2008 Q2 | -780.86 Thousand USD | 79.02% |
| 2008 Q3 | -2.3 Million USD | -194.56% |
| 2007 Q1 | -2.09 Million USD | -321.6% |
| 2007 FY | - USD | -239.85% |
| 2007 Q4 | -3.55 Million USD | -89.24% |
| 2007 Q3 | -1.87 Million USD | -38.52% |
| 2007 Q2 | -1.35 Million USD | 35.22% |
| 2006 Q2 | -1.29 Million USD | -30.7% |
| 2006 Q1 | -991.41 Thousand USD | -31.79% |
| 2006 FY | - USD | 46.54% |
| 2006 Q4 | 943.38 Thousand USD | 174.61% |
| 2006 Q3 | -1.26 Million USD | 2.43% |
| 2005 Q3 | -944.54 Thousand USD | 8.8% |
| 2005 Q2 | -1.03 Million USD | 10.54% |
| 2005 Q1 | -1.15 Million USD | -20.56% |
| 2005 FY | - USD | -27.98% |
| 2005 Q4 | -752.24 Thousand USD | 20.36% |
| 2004 Q4 | -960.33 Thousand USD | -11.99% |
| 2004 Q3 | -857.53 Thousand USD | 26.45% |
| 2004 Q2 | -1.16 Million USD | -40.77% |
| 2004 Q1 | -828.27 Thousand USD | -932.81% |
| 2004 FY | - USD | -131.39% |
| 2003 Q2 | -682.67 Thousand USD | -0.44% |
| 2003 Q1 | -679.68 Thousand USD | 29.29% |
| 2003 Q3 | -204.95 Thousand USD | 69.98% |
| 2003 FY | - USD | 58.71% |
| 2003 Q4 | -80.19 Thousand USD | 60.87% |
| 2002 Q1 | -2.85 Million USD | -4.07% |
| 2002 Q4 | -961.23 Thousand USD | -50771.11% |
| 2002 Q3 | 88.22 Thousand USD | 100.53% |
| 2002 Q2 | -312.72 Thousand USD | 87.87% |
| 2002 FY | - USD | 64.09% |
| 2001 Q4 | -2.74 Million USD | -39.28% |
| 2001 Q1 | -2.49 Million USD | -75.95% |
| 2001 Q2 | -3.58 Million USD | -41.97% |
| 2001 Q3 | -1.99 Million USD | 43.5% |
| 2001 FY | - USD | -33.27% |
| 2000 Q2 | -2.83 Million USD | -77.44% |
| 2000 FY | - USD | -12.68% |
| 2000 Q1 | -1.69 Million USD | 15.79% |
| 2000 Q4 | -1.44 Million USD | 36.72% |
| 2000 Q3 | -2.29 Million USD | 18.99% |
| 1999 Q2 | -2.2 Million USD | -29.41% |
| 1999 Q3 | -1.6 Million USD | 27.27% |
| 1999 Q4 | -1.9 Million USD | -18.75% |
| 1999 FY | - USD | 2.63% |
| 1999 Q1 | -1.4 Million USD | 32.0% |
| 1998 FY | - USD | 5.0% |
| 1998 Q1 | -1.5 Million USD | -45.45% |
| 1998 Q2 | -1.4 Million USD | 12.5% |
| 1998 Q3 | -1.6 Million USD | -28.57% |
| 1998 Q4 | -2.2 Million USD | -38.89% |
| 1997 Q4 | -1.4 Million USD | 38.89% |
| 1997 Q2 | -3.5 Million USD | -200.0% |
| 1997 Q3 | -1.8 Million USD | 50.0% |
| 1997 FY | - USD | -29.03% |
| 1997 Q1 | -1.2 Million USD | 36.84% |
| 1996 Q3 | -1.4 Million USD | -27.27% |
| 1996 Q1 | -1.6 Million USD | -112.5% |
| 1996 FY | - USD | -87.88% |
| 1996 Q4 | -1.9 Million USD | -35.71% |
| 1996 Q2 | -1.1 Million USD | 35.29% |
| 1995 Q3 | -600 Thousand USD | 28.57% |
| 1995 Q1 | -900 Thousand USD | 30.0% |
| 1995 Q2 | -800 Thousand USD | 0.0% |
| 1995 Q4 | -800 Thousand USD | -60.0% |
| 1995 FY | - USD | 31.25% |
| 1994 Q2 | -800 Thousand USD | -60.0% |
| 1994 Q3 | -1.3 Million USD | -62.5% |
| 1994 Q4 | -1 Million USD | 23.08% |
| 1994 FY | - USD | -182.35% |
| 1994 Q1 | -500 Thousand USD | 37.5% |
| 1993 Q1 | -100 Thousand USD | 85.71% |
| 1993 Q4 | -800 Thousand USD | -100.0% |
| 1993 Q2 | -600 Thousand USD | -500.0% |
| 1993 FY | - USD | -54.55% |
| 1993 Q3 | -400 Thousand USD | 33.33% |
| 1992 Q4 | -700 Thousand USD | -600.0% |
| 1992 Q1 | -300 Thousand USD | 0.0% |
| 1992 Q2 | -200 Thousand USD | 33.33% |
| 1992 FY | - USD | -120.0% |
| 1992 Q3 | -100 Thousand USD | 50.0% |
| 1991 Q2 | 100 Thousand USD | 150.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| 1991 Q4 | -300 Thousand USD | -400.0% |
| 1991 Q1 | -200 Thousand USD | 0.0% |
| 1991 FY | - USD | -25.0% |
| 1990 FY | - USD | 42.86% |
| 1990 Q4 | -200 Thousand USD | -100.0% |
| 1990 Q3 | -100 Thousand USD | 0.0% |
| 1990 Q2 | -100 Thousand USD | 50.0% |
| 1990 Q1 | -200 Thousand USD | 60.0% |
| 1989 Q3 | -200 Thousand USD | -300.0% |
| 1989 Q4 | -500 Thousand USD | -150.0% |
| 1989 Q2 | 100 Thousand USD | 200.0% |
| 1989 Q1 | -100 Thousand USD | 93.33% |
| 1989 FY | - USD | 41.67% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -31.67 Million USD | 12.998% |
| Ampio Pharmaceuticals, Inc. | - USD | Infinity% |
| Armata Pharmaceuticals, Inc. | -39.91 Million USD | 30.957% |
| Actinium Pharmaceuticals, Inc. | -51.13 Million USD | 46.097% |
| Azitra, Inc. | -10.67 Million USD | -158.222% |
| Can-Fite BioPharma Ltd. | -8.18 Million USD | -236.926% |
| Chromocell Therapeutics Corporation | -6.86 Million USD | -301.624% |
| Calidi Biotherapeutics, Inc. | -28.6 Million USD | 3.634% |
| iBio, Inc. | -14.02 Million USD | -96.566% |
| Lineage Cell Therapeutics, Inc. | -24.73 Million USD | -11.432% |
| MAIA Biotechnology, Inc. | -20.18 Million USD | -36.557% |
| Matinas BioPharma Holdings, Inc. | -22.82 Million USD | -20.747% |
| Navidea Biopharmaceuticals, Inc. | -13.87 Million USD | -98.633% |
| NovaBay Pharmaceuticals, Inc. | -4.8 Million USD | -474.178% |
| NanoViricides, Inc. | -7.75 Million USD | -255.295% |
| Oragenics, Inc. | -20.87 Million USD | -32.011% |
| BiomX Inc. | -22.81 Million USD | -20.8% |
| BiomX Inc. | -22.81 Million USD | -20.8% |
| Protalix BioTherapeutics, Inc. | 11.65 Million USD | 336.551% |
| Palatin Technologies, Inc. | -29.03 Million USD | 5.066% |
| Scorpius Holdings, Inc. | -35.08 Million USD | 21.441% |